Please Wait.....
Report
Ventricular Assist Devices Market By Product (Left Ventricular Assist Devices (LVADs), Right Ventricular Assist Devices (RVADs), Biventricular Assist Devices (BIVADs)), By Application (Bridge-To-Transplant (BTT), Destination Therapy, Bridge-To-Recovery (BTR), Bridge To Candidacy Therapy), By Design (Transcutaneous Ventricular Assist Devices, Implantable Ventricular Assist Devices), By Age (Adults, Pediatrics): Global Opportunity Analysis and Industry Forecast, 2021-2031
Market Report I 2023-02-01 I 316 Pages I Allied Market Research
The ventricular assist devices market valued for $1,338.53 million in 2021 and is estimated to reach $2,880.66 million by 2031, exhibiting a CAGR of 7.9% from 2022 to 2031.
Ventricular assist device (VAD), also known as mechanical circulatory support (MCS) device, supports the pumping function of the heart. It is used to increase the amount of blood that flows through the patient's body. It enables a patient with advanced heart failure to lead an improved quality of life once again. A ventricular assist device (VAD) helps in supporting either of the right or the left ventricle, however, is mostly implanted in the left ventricle. When placed in the left ventricle, it is called a left ventricular assist device (LVAD).
Ventricular assist devices are commonly used in treatment of heart failure. The VAD transplant can be temporary or permanent depending on the function for which it is implanted. They are implanted temporarily when the patient is either waiting for a heart transplant or is receiving treatment to help the heart recover until it is healthy enough to pump blood on its own.
On the other hand, it is implanted permanently to ensure proper blood flow through the heart in the patient with abnormal ventricle function. Such applications of ventricular assist devices in treatment of heart failure increases its demand in the healthcare sector and thus boost the growth of the market. In addition, rise in awareness among the patients and healthcare practitioners about ventricular assist devices fosters the market growth.
Moreover, there are initiatives taken up by the governments and other organizations in creating awareness among the people regarding cardiovascular diseases and its advanced treatment options. For instance, the National Health Service (NHS) Long Term Plan for England designated heart failure as a priority in 2019, with a focus on promoting earlier detection of heart failure in the community through primary care networks (PCNs), a stronger emphasis on multidisciplinary teams (MDT)-led care, and quicker access to specialized care in hospitals. Such awareness programs initiated by various organizations increase the public awareness about advanced treatment options in heart failure including the ventricular assist devices. This further leads to the expansion of the ventricular assist devices market.
Although, various key factors are driving the growth of the market, there are few factors such as high cost associated with the device & implantation and serious risks involved in the procedure are hampering the growth of the market. These high prices create limitations in accessing ventricular assist devices majorly in developing and underdeveloped countries. Moreover, lack of awareness about advanced treatment procedures for heart failure among the people in underdeveloped countries also acts as a restraint to the growth of the market. In addition, implanting a VAD may result in blood clots and bleeding from the surgery that may cause infection and device malfunction, which act as a restraint to the market.
On the other hand, the key market players are investing on a large scale for the R&D activities related to ventricular assist devices. Companies are focusing on innovation to develop advanced ventricular assist devices that can overcome the drawbacks of the existing VADs. Moreover, large number of clinical and developmental studies are carried out to prove the efficiency of the devices, and to get the approval for the same. This is anticipated to drive the market expansion during the forecast period.
For instance, in October 2022, Abiomed announced that Impella RP Flex with SmartAssist received U.S. Food and Drug Administration (FDA) pre-market approval (PMA), as safe and effective to treat acute right heart failure for up to 14 days. Thus, more such product approvals and launches contribute to the growth of the market. Moreover, surge in incidences of heart failure across the globe, new technological advancements in ventricular assist devices, awareness among patients about monitoring of the heart, and shortage of heart donors drive the market growth.
The ventricular assist devices market is segmented on the basis of product, application, design, age, and region. By product, the market is categorized into left ventricular assist devices (LVADs), right ventricular assist devices (RVADs), and biventricular assist devices (BIVADs). On the basis of application, the market is fragmented into bridge-to-transplant (BTT), destination therapy, bridge-to-recovery (BTR), and bridge to candidacy therapy.
On the basis of design, the market is bifurcated into transcutaneous ventricular assist devices and implantable ventricular assist devices. By age, the market is divided into adults and pediatrics. Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
Major Key players that operate in the global ventricular assist devices market are Abbott Laboratories, Abiomed, Inc., AdjuCor GmbH, Berlin Heart GmbH, Bivacor Inc., Calon Cardio-Technology Ltd, Carmat SA, CH Biomedical, Inc., Corewave SA, Evaheart, Inc., Fineheart, Jarvik Heart, Inc., LivaNova PLC, NuPulseCV, Inc., SynCardia Systems, LLC, and Windmill Cardiovascular Systems.
Key Benefits For Stakeholders
-This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the ventricular assist devices market analysis from 2021 to 2031 to identify the prevailing ventricular assist devices market opportunities.
-The market research is offered along with information related to key drivers, restraints, and opportunities.
-Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
-In-depth analysis of the ventricular assist devices market segmentation assists to determine the prevailing market opportunities.
-Major countries in each region are mapped according to their revenue contribution to the global market.
-Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
-The report includes the analysis of the regional as well as global ventricular assist devices market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Product
- Left Ventricular Assist Devices (LVADs)
- Right Ventricular Assist Devices (RVADs)
- Biventricular Assist Devices (BIVADs)
By Application
- Bridge-To-Transplant (BTT)
- Destination Therapy
- Bridge-To-Recovery (BTR)
- Bridge To Candidacy Therapy
By Design
- Transcutaneous Ventricular Assist Devices
- Implantable Ventricular Assist Devices
By Age
- Adults
- Pediatrics
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
- Key Market Players
- Evaheart, Inc.
- Abiomed, Inc.
- Abbott Laboratories
- CH Biomedical, Inc.
- Carmat SA
- Calon Cardio-Technology Ltd
- Bivacor Inc.
- LivaNova PLC
- Berlin Heart GmbH
- Fineheart
- AdjuCor GmbH
- NuPulseCV, Inc.
- Jarvik Heart, Inc.
- SynCardia Systems, LLC
- Corewave SA
- Windmill Cardiovascular Systems
CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research Methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top impacting factors
3.2.2. Top investment pockets
3.3. Porter's five forces analysis
3.3.1. Bargaining power of suppliers
3.3.2. Bargaining power of buyers
3.3.3. Threat of substitutes
3.3.4. Threat of new entrants
3.3.5. Intensity of rivalry
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Increase in incidence of heart failures
3.4.1.2. Technological advancements
3.4.1.3. Rise in patient awareness about heart failure treatment options
3.4.1.4. Dearth of heart donors
3.4.2. Restraints
3.4.2.1. High cost of devices and procedures
3.4.2.2. Serious risks involved in the procedure
3.4.3. Opportunities
3.4.3.1. Lucrative opportunities in the emerging markets
3.5. COVID-19 Impact Analysis on the market
CHAPTER 4: VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT
4.1. Overview
4.1.1. Market size and forecast
4.2. Left Ventricular Assist Devices (LVADs)
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market share analysis by country
4.3. Right Ventricular Assist Devices (RVADs)
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market share analysis by country
4.4. Biventricular Assist Devices (BIVADs)
4.4.1. Key market trends, growth factors and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market share analysis by country
CHAPTER 5: VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION
5.1. Overview
5.1.1. Market size and forecast
5.2. Bridge-To-Transplant (BTT)
5.2.1. Key market trends, growth factors and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market share analysis by country
5.3. Destination Therapy
5.3.1. Key market trends, growth factors and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market share analysis by country
5.4. Bridge-To-Recovery (BTR)
5.4.1. Key market trends, growth factors and opportunities
5.4.2. Market size and forecast, by region
5.4.3. Market share analysis by country
5.5. Bridge To Candidacy Therapy
5.5.1. Key market trends, growth factors and opportunities
5.5.2. Market size and forecast, by region
5.5.3. Market share analysis by country
CHAPTER 6: VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN
6.1. Overview
6.1.1. Market size and forecast
6.2. Transcutaneous Ventricular Assist Devices
6.2.1. Key market trends, growth factors and opportunities
6.2.2. Market size and forecast, by region
6.2.3. Market share analysis by country
6.3. Implantable Ventricular Assist Devices
6.3.1. Key market trends, growth factors and opportunities
6.3.2. Market size and forecast, by region
6.3.3. Market share analysis by country
CHAPTER 7: VENTRICULAR ASSIST DEVICES MARKET, BY AGE
7.1. Overview
7.1.1. Market size and forecast
7.2. Adults
7.2.1. Key market trends, growth factors and opportunities
7.2.2. Market size and forecast, by region
7.2.3. Market share analysis by country
7.3. Pediatrics
7.3.1. Key market trends, growth factors and opportunities
7.3.2. Market size and forecast, by region
7.3.3. Market share analysis by country
CHAPTER 8: VENTRICULAR ASSIST DEVICES MARKET, BY REGION
8.1. Overview
8.1.1. Market size and forecast By Region
8.2. North America
8.2.1. Key trends and opportunities
8.2.2. Market size and forecast, by Product
8.2.3. Market size and forecast, by Application
8.2.4. Market size and forecast, by Design
8.2.5. Market size and forecast, by Age
8.2.6. Market size and forecast, by country
8.2.6.1. U.S.
8.2.6.1.1. Key market trends, growth factors and opportunities
8.2.6.1.2. Market size and forecast, by Product
8.2.6.1.3. Market size and forecast, by Application
8.2.6.1.4. Market size and forecast, by Design
8.2.6.1.5. Market size and forecast, by Age
8.2.6.2. Canada
8.2.6.2.1. Key market trends, growth factors and opportunities
8.2.6.2.2. Market size and forecast, by Product
8.2.6.2.3. Market size and forecast, by Application
8.2.6.2.4. Market size and forecast, by Design
8.2.6.2.5. Market size and forecast, by Age
8.2.6.3. Mexico
8.2.6.3.1. Key market trends, growth factors and opportunities
8.2.6.3.2. Market size and forecast, by Product
8.2.6.3.3. Market size and forecast, by Application
8.2.6.3.4. Market size and forecast, by Design
8.2.6.3.5. Market size and forecast, by Age
8.3. Europe
8.3.1. Key trends and opportunities
8.3.2. Market size and forecast, by Product
8.3.3. Market size and forecast, by Application
8.3.4. Market size and forecast, by Design
8.3.5. Market size and forecast, by Age
8.3.6. Market size and forecast, by country
8.3.6.1. Germany
8.3.6.1.1. Key market trends, growth factors and opportunities
8.3.6.1.2. Market size and forecast, by Product
8.3.6.1.3. Market size and forecast, by Application
8.3.6.1.4. Market size and forecast, by Design
8.3.6.1.5. Market size and forecast, by Age
8.3.6.2. France
8.3.6.2.1. Key market trends, growth factors and opportunities
8.3.6.2.2. Market size and forecast, by Product
8.3.6.2.3. Market size and forecast, by Application
8.3.6.2.4. Market size and forecast, by Design
8.3.6.2.5. Market size and forecast, by Age
8.3.6.3. UK
8.3.6.3.1. Key market trends, growth factors and opportunities
8.3.6.3.2. Market size and forecast, by Product
8.3.6.3.3. Market size and forecast, by Application
8.3.6.3.4. Market size and forecast, by Design
8.3.6.3.5. Market size and forecast, by Age
8.3.6.4. Italy
8.3.6.4.1. Key market trends, growth factors and opportunities
8.3.6.4.2. Market size and forecast, by Product
8.3.6.4.3. Market size and forecast, by Application
8.3.6.4.4. Market size and forecast, by Design
8.3.6.4.5. Market size and forecast, by Age
8.3.6.5. Spain
8.3.6.5.1. Key market trends, growth factors and opportunities
8.3.6.5.2. Market size and forecast, by Product
8.3.6.5.3. Market size and forecast, by Application
8.3.6.5.4. Market size and forecast, by Design
8.3.6.5.5. Market size and forecast, by Age
8.3.6.6. Rest of Europe
8.3.6.6.1. Key market trends, growth factors and opportunities
8.3.6.6.2. Market size and forecast, by Product
8.3.6.6.3. Market size and forecast, by Application
8.3.6.6.4. Market size and forecast, by Design
8.3.6.6.5. Market size and forecast, by Age
8.4. Asia-Pacific
8.4.1. Key trends and opportunities
8.4.2. Market size and forecast, by Product
8.4.3. Market size and forecast, by Application
8.4.4. Market size and forecast, by Design
8.4.5. Market size and forecast, by Age
8.4.6. Market size and forecast, by country
8.4.6.1. Japan
8.4.6.1.1. Key market trends, growth factors and opportunities
8.4.6.1.2. Market size and forecast, by Product
8.4.6.1.3. Market size and forecast, by Application
8.4.6.1.4. Market size and forecast, by Design
8.4.6.1.5. Market size and forecast, by Age
8.4.6.2. China
8.4.6.2.1. Key market trends, growth factors and opportunities
8.4.6.2.2. Market size and forecast, by Product
8.4.6.2.3. Market size and forecast, by Application
8.4.6.2.4. Market size and forecast, by Design
8.4.6.2.5. Market size and forecast, by Age
8.4.6.3. Australia
8.4.6.3.1. Key market trends, growth factors and opportunities
8.4.6.3.2. Market size and forecast, by Product
8.4.6.3.3. Market size and forecast, by Application
8.4.6.3.4. Market size and forecast, by Design
8.4.6.3.5. Market size and forecast, by Age
8.4.6.4. India
8.4.6.4.1. Key market trends, growth factors and opportunities
8.4.6.4.2. Market size and forecast, by Product
8.4.6.4.3. Market size and forecast, by Application
8.4.6.4.4. Market size and forecast, by Design
8.4.6.4.5. Market size and forecast, by Age
8.4.6.5. South Korea
8.4.6.5.1. Key market trends, growth factors and opportunities
8.4.6.5.2. Market size and forecast, by Product
8.4.6.5.3. Market size and forecast, by Application
8.4.6.5.4. Market size and forecast, by Design
8.4.6.5.5. Market size and forecast, by Age
8.4.6.6. Rest of Asia-Pacific
8.4.6.6.1. Key market trends, growth factors and opportunities
8.4.6.6.2. Market size and forecast, by Product
8.4.6.6.3. Market size and forecast, by Application
8.4.6.6.4. Market size and forecast, by Design
8.4.6.6.5. Market size and forecast, by Age
8.5. LAMEA
8.5.1. Key trends and opportunities
8.5.2. Market size and forecast, by Product
8.5.3. Market size and forecast, by Application
8.5.4. Market size and forecast, by Design
8.5.5. Market size and forecast, by Age
8.5.6. Market size and forecast, by country
8.5.6.1. Brazil
8.5.6.1.1. Key market trends, growth factors and opportunities
8.5.6.1.2. Market size and forecast, by Product
8.5.6.1.3. Market size and forecast, by Application
8.5.6.1.4. Market size and forecast, by Design
8.5.6.1.5. Market size and forecast, by Age
8.5.6.2. Saudi Arabia
8.5.6.2.1. Key market trends, growth factors and opportunities
8.5.6.2.2. Market size and forecast, by Product
8.5.6.2.3. Market size and forecast, by Application
8.5.6.2.4. Market size and forecast, by Design
8.5.6.2.5. Market size and forecast, by Age
8.5.6.3. South Africa
8.5.6.3.1. Key market trends, growth factors and opportunities
8.5.6.3.2. Market size and forecast, by Product
8.5.6.3.3. Market size and forecast, by Application
8.5.6.3.4. Market size and forecast, by Design
8.5.6.3.5. Market size and forecast, by Age
8.5.6.4. Rest of LAMEA
8.5.6.4.1. Key market trends, growth factors and opportunities
8.5.6.4.2. Market size and forecast, by Product
8.5.6.4.3. Market size and forecast, by Application
8.5.6.4.4. Market size and forecast, by Design
8.5.6.4.5. Market size and forecast, by Age
CHAPTER 9: COMPETITIVE LANDSCAPE
9.1. Introduction
9.2. Top winning strategies
9.3. Product Mapping of Top 10 Player
9.4. Competitive Dashboard
9.5. Competitive Heatmap
9.6. Top player positioning, 2021
CHAPTER 10: COMPANY PROFILES
10.1. Evaheart, Inc.
10.1.1. Company overview
10.1.2. Key Executives
10.1.3. Company snapshot
10.1.4. Operating business segments
10.1.5. Product portfolio
10.1.6. Key strategic moves and developments
10.2. Calon Cardio-Technology Ltd
10.2.1. Company overview
10.2.2. Key Executives
10.2.3. Company snapshot
10.2.4. Operating business segments
10.2.5. Product portfolio
10.3. Carmat SA
10.3.1. Company overview
10.3.2. Key Executives
10.3.3. Company snapshot
10.3.4. Operating business segments
10.3.5. Product portfolio
10.3.6. Key strategic moves and developments
10.4. Fineheart
10.4.1. Company overview
10.4.2. Key Executives
10.4.3. Company snapshot
10.4.4. Operating business segments
10.4.5. Product portfolio
10.4.6. Key strategic moves and developments
10.5. AdjuCor GmbH
10.5.1. Company overview
10.5.2. Key Executives
10.5.3. Company snapshot
10.5.4. Operating business segments
10.5.5. Product portfolio
10.6. Corewave SA
10.6.1. Company overview
10.6.2. Key Executives
10.6.3. Company snapshot
10.6.4. Operating business segments
10.6.5. Product portfolio
10.6.6. Key strategic moves and developments
10.7. Bivacor Inc.
10.7.1. Company overview
10.7.2. Key Executives
10.7.3. Company snapshot
10.7.4. Operating business segments
10.7.5. Product portfolio
10.7.6. Key strategic moves and developments
10.8. Windmill Cardiovascular Systems
10.8.1. Company overview
10.8.2. Key Executives
10.8.3. Company snapshot
10.8.4. Operating business segments
10.8.5. Product portfolio
10.9. NuPulseCV, Inc.
10.9.1. Company overview
10.9.2. Key Executives
10.9.3. Company snapshot
10.9.4. Operating business segments
10.9.5. Product portfolio
10.10. Abiomed, Inc.
10.10.1. Company overview
10.10.2. Key Executives
10.10.3. Company snapshot
10.10.4. Operating business segments
10.10.5. Product portfolio
10.10.6. Business performance
10.10.7. Key strategic moves and developments
10.11. LivaNova PLC
10.11.1. Company overview
10.11.2. Key Executives
10.11.3. Company snapshot
10.11.4. Operating business segments
10.11.5. Product portfolio
10.11.6. Business performance
10.11.7. Key strategic moves and developments
10.12. Berlin Heart GmbH
10.12.1. Company overview
10.12.2. Key Executives
10.12.3. Company snapshot
10.12.4. Operating business segments
10.12.5. Product portfolio
10.12.6. Key strategic moves and developments
10.13. Jarvik Heart, Inc.
10.13.1. Company overview
10.13.2. Key Executives
10.13.3. Company snapshot
10.13.4. Operating business segments
10.13.5. Product portfolio
10.14. Abbott Laboratories
10.14.1. Company overview
10.14.2. Key Executives
10.14.3. Company snapshot
10.14.4. Operating business segments
10.14.5. Product portfolio
10.14.6. Business performance
10.14.7. Key strategic moves and developments
10.15. SynCardia Systems, LLC
10.15.1. Company overview
10.15.2. Key Executives
10.15.3. Company snapshot
10.15.4. Operating business segments
10.15.5. Product portfolio
10.15.6. Key strategic moves and developments
10.16. CH Biomedical, Inc.
10.16.1. Company overview
10.16.2. Key Executives
10.16.3. Company snapshot
10.16.4. Operating business segments
10.16.5. Product portfolio
10.16.6. Key strategic moves and developments
LIST OF TABLES
TABLE 01. GLOBAL VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 02. VENTRICULAR ASSIST DEVICES MARKET FOR LEFT VENTRICULAR ASSIST DEVICES (LVADS), BY REGION, 2021-2031 ($MILLION)
TABLE 03. VENTRICULAR ASSIST DEVICES MARKET FOR RIGHT VENTRICULAR ASSIST DEVICES (RVADS), BY REGION, 2021-2031 ($MILLION)
TABLE 04. VENTRICULAR ASSIST DEVICES MARKET FOR BIVENTRICULAR ASSIST DEVICES (BIVADS), BY REGION, 2021-2031 ($MILLION)
TABLE 05. GLOBAL VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 06. VENTRICULAR ASSIST DEVICES MARKET FOR BRIDGE-TO-TRANSPLANT (BTT), BY REGION, 2021-2031 ($MILLION)
TABLE 07. VENTRICULAR ASSIST DEVICES MARKET FOR DESTINATION THERAPY, BY REGION, 2021-2031 ($MILLION)
TABLE 08. VENTRICULAR ASSIST DEVICES MARKET FOR BRIDGE-TO-RECOVERY (BTR), BY REGION, 2021-2031 ($MILLION)
TABLE 09. VENTRICULAR ASSIST DEVICES MARKET FOR BRIDGE TO CANDIDACY THERAPY, BY REGION, 2021-2031 ($MILLION)
TABLE 10. GLOBAL VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2021-2031 ($MILLION)
TABLE 11. VENTRICULAR ASSIST DEVICES MARKET FOR TRANSCUTANEOUS VENTRICULAR ASSIST DEVICES, BY REGION, 2021-2031 ($MILLION)
TABLE 12. VENTRICULAR ASSIST DEVICES MARKET FOR IMPLANTABLE VENTRICULAR ASSIST DEVICES, BY REGION, 2021-2031 ($MILLION)
TABLE 13. GLOBAL VENTRICULAR ASSIST DEVICES MARKET, BY AGE, 2021-2031 ($MILLION)
TABLE 14. VENTRICULAR ASSIST DEVICES MARKET FOR ADULTS, BY REGION, 2021-2031 ($MILLION)
TABLE 15. VENTRICULAR ASSIST DEVICES MARKET FOR PEDIATRICS, BY REGION, 2021-2031 ($MILLION)
TABLE 16. VENTRICULAR ASSIST DEVICES MARKET, BY REGION, 2021-2031 ($MILLION)
TABLE 17. NORTH AMERICA VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 18. NORTH AMERICA VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 19. NORTH AMERICA VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2021-2031 ($MILLION)
TABLE 20. NORTH AMERICA VENTRICULAR ASSIST DEVICES MARKET, BY AGE, 2021-2031 ($MILLION)
TABLE 21. NORTH AMERICA VENTRICULAR ASSIST DEVICES MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 22. U.S. VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 23. U.S. VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 24. U.S. VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2021-2031 ($MILLION)
TABLE 25. U.S. VENTRICULAR ASSIST DEVICES MARKET, BY AGE, 2021-2031 ($MILLION)
TABLE 26. CANADA VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 27. CANADA VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 28. CANADA VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2021-2031 ($MILLION)
TABLE 29. CANADA VENTRICULAR ASSIST DEVICES MARKET, BY AGE, 2021-2031 ($MILLION)
TABLE 30. MEXICO VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 31. MEXICO VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 32. MEXICO VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2021-2031 ($MILLION)
TABLE 33. MEXICO VENTRICULAR ASSIST DEVICES MARKET, BY AGE, 2021-2031 ($MILLION)
TABLE 34. EUROPE VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 35. EUROPE VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 36. EUROPE VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2021-2031 ($MILLION)
TABLE 37. EUROPE VENTRICULAR ASSIST DEVICES MARKET, BY AGE, 2021-2031 ($MILLION)
TABLE 38. EUROPE VENTRICULAR ASSIST DEVICES MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 39. GERMANY VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 40. GERMANY VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 41. GERMANY VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2021-2031 ($MILLION)
TABLE 42. GERMANY VENTRICULAR ASSIST DEVICES MARKET, BY AGE, 2021-2031 ($MILLION)
TABLE 43. FRANCE VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 44. FRANCE VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 45. FRANCE VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2021-2031 ($MILLION)
TABLE 46. FRANCE VENTRICULAR ASSIST DEVICES MARKET, BY AGE, 2021-2031 ($MILLION)
TABLE 47. UK VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 48. UK VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 49. UK VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2021-2031 ($MILLION)
TABLE 50. UK VENTRICULAR ASSIST DEVICES MARKET, BY AGE, 2021-2031 ($MILLION)
TABLE 51. ITALY VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 52. ITALY VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 53. ITALY VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2021-2031 ($MILLION)
TABLE 54. ITALY VENTRICULAR ASSIST DEVICES MARKET, BY AGE, 2021-2031 ($MILLION)
TABLE 55. SPAIN VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 56. SPAIN VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 57. SPAIN VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2021-2031 ($MILLION)
TABLE 58. SPAIN VENTRICULAR ASSIST DEVICES MARKET, BY AGE, 2021-2031 ($MILLION)
TABLE 59. REST OF EUROPE VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 60. REST OF EUROPE VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 61. REST OF EUROPE VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2021-2031 ($MILLION)
TABLE 62. REST OF EUROPE VENTRICULAR ASSIST DEVICES MARKET, BY AGE, 2021-2031 ($MILLION)
TABLE 63. ASIA-PACIFIC VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 64. ASIA-PACIFIC VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 65. ASIA-PACIFIC VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2021-2031 ($MILLION)
TABLE 66. ASIA-PACIFIC VENTRICULAR ASSIST DEVICES MARKET, BY AGE, 2021-2031 ($MILLION)
TABLE 67. ASIA-PACIFIC VENTRICULAR ASSIST DEVICES MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 68. JAPAN VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 69. JAPAN VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 70. JAPAN VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2021-2031 ($MILLION)
TABLE 71. JAPAN VENTRICULAR ASSIST DEVICES MARKET, BY AGE, 2021-2031 ($MILLION)
TABLE 72. CHINA VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 73. CHINA VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 74. CHINA VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2021-2031 ($MILLION)
TABLE 75. CHINA VENTRICULAR ASSIST DEVICES MARKET, BY AGE, 2021-2031 ($MILLION)
TABLE 76. AUSTRALIA VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 77. AUSTRALIA VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 78. AUSTRALIA VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2021-2031 ($MILLION)
TABLE 79. AUSTRALIA VENTRICULAR ASSIST DEVICES MARKET, BY AGE, 2021-2031 ($MILLION)
TABLE 80. INDIA VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 81. INDIA VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 82. INDIA VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2021-2031 ($MILLION)
TABLE 83. INDIA VENTRICULAR ASSIST DEVICES MARKET, BY AGE, 2021-2031 ($MILLION)
TABLE 84. SOUTH KOREA VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 85. SOUTH KOREA VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 86. SOUTH KOREA VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2021-2031 ($MILLION)
TABLE 87. SOUTH KOREA VENTRICULAR ASSIST DEVICES MARKET, BY AGE, 2021-2031 ($MILLION)
TABLE 88. REST OF ASIA-PACIFIC VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 89. REST OF ASIA-PACIFIC VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 90. REST OF ASIA-PACIFIC VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2021-2031 ($MILLION)
TABLE 91. REST OF ASIA-PACIFIC VENTRICULAR ASSIST DEVICES MARKET, BY AGE, 2021-2031 ($MILLION)
TABLE 92. LAMEA VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 93. LAMEA VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 94. LAMEA VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2021-2031 ($MILLION)
TABLE 95. LAMEA VENTRICULAR ASSIST DEVICES MARKET, BY AGE, 2021-2031 ($MILLION)
TABLE 96. LAMEA VENTRICULAR ASSIST DEVICES MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 97. BRAZIL VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 98. BRAZIL VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 99. BRAZIL VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2021-2031 ($MILLION)
TABLE 100. BRAZIL VENTRICULAR ASSIST DEVICES MARKET, BY AGE, 2021-2031 ($MILLION)
TABLE 101. SAUDI ARABIA VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 102. SAUDI ARABIA VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 103. SAUDI ARABIA VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2021-2031 ($MILLION)
TABLE 104. SAUDI ARABIA VENTRICULAR ASSIST DEVICES MARKET, BY AGE, 2021-2031 ($MILLION)
TABLE 105. SOUTH AFRICA VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 106. SOUTH AFRICA VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 107. SOUTH AFRICA VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2021-2031 ($MILLION)
TABLE 108. SOUTH AFRICA VENTRICULAR ASSIST DEVICES MARKET, BY AGE, 2021-2031 ($MILLION)
TABLE 109. REST OF LAMEA VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 110. REST OF LAMEA VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 111. REST OF LAMEA VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2021-2031 ($MILLION)
TABLE 112. REST OF LAMEA VENTRICULAR ASSIST DEVICES MARKET, BY AGE, 2021-2031 ($MILLION)
TABLE 113. EVAHEART, INC.: KEY EXECUTIVES
TABLE 114. EVAHEART, INC.: COMPANY SNAPSHOT
TABLE 115. EVAHEART, INC.: PRODUCT SEGMENTS
TABLE 116. EVAHEART, INC.: PRODUCT PORTFOLIO
TABLE 117. EVAHEART, INC.: KEY STRATERGIES
TABLE 118. CALON CARDIO-TECHNOLOGY LTD: KEY EXECUTIVES
TABLE 119. CALON CARDIO-TECHNOLOGY LTD: COMPANY SNAPSHOT
TABLE 120. CALON CARDIO-TECHNOLOGY LTD: PRODUCT SEGMENTS
TABLE 121. CALON CARDIO-TECHNOLOGY LTD: PRODUCT PORTFOLIO
TABLE 122. CARMAT SA: KEY EXECUTIVES
TABLE 123. CARMAT SA: COMPANY SNAPSHOT
TABLE 124. CARMAT SA: PRODUCT SEGMENTS
TABLE 125. CARMAT SA: PRODUCT PORTFOLIO
TABLE 126. CARMAT SA: KEY STRATERGIES
TABLE 127. FINEHEART: KEY EXECUTIVES
TABLE 128. FINEHEART: COMPANY SNAPSHOT
TABLE 129. FINEHEART: PRODUCT SEGMENTS
TABLE 130. FINEHEART: PRODUCT PORTFOLIO
TABLE 131. FINEHEART: KEY STRATERGIES
TABLE 132. ADJUCOR GMBH: KEY EXECUTIVES
TABLE 133. ADJUCOR GMBH: COMPANY SNAPSHOT
TABLE 134. ADJUCOR GMBH: PRODUCT SEGMENTS
TABLE 135. ADJUCOR GMBH: PRODUCT PORTFOLIO
TABLE 136. COREWAVE SA: KEY EXECUTIVES
TABLE 137. COREWAVE SA: COMPANY SNAPSHOT
TABLE 138. COREWAVE SA: PRODUCT SEGMENTS
TABLE 139. COREWAVE SA: PRODUCT PORTFOLIO
TABLE 140. COREWAVE SA: KEY STRATERGIES
TABLE 141. BIVACOR INC.: KEY EXECUTIVES
TABLE 142. BIVACOR INC.: COMPANY SNAPSHOT
TABLE 143. BIVACOR INC.: PRODUCT SEGMENTS
TABLE 144. BIVACOR INC.: PRODUCT PORTFOLIO
TABLE 145. BIVACOR INC.: KEY STRATERGIES
TABLE 146. WINDMILL CARDIOVASCULAR SYSTEMS: KEY EXECUTIVES
TABLE 147. WINDMILL CARDIOVASCULAR SYSTEMS: COMPANY SNAPSHOT
TABLE 148. WINDMILL CARDIOVASCULAR SYSTEMS: PRODUCT SEGMENTS
TABLE 149. WINDMILL CARDIOVASCULAR SYSTEMS: PRODUCT PORTFOLIO
TABLE 150. NUPULSECV, INC.: KEY EXECUTIVES
TABLE 151. NUPULSECV, INC.: COMPANY SNAPSHOT
TABLE 152. NUPULSECV, INC.: PRODUCT SEGMENTS
TABLE 153. NUPULSECV, INC.: PRODUCT PORTFOLIO
TABLE 154. ABIOMED, INC.: KEY EXECUTIVES
TABLE 155. ABIOMED, INC.: COMPANY SNAPSHOT
TABLE 156. ABIOMED, INC.: PRODUCT SEGMENTS
TABLE 157. ABIOMED, INC.: PRODUCT PORTFOLIO
TABLE 158. ABIOMED, INC.: KEY STRATERGIES
TABLE 159. LIVANOVA PLC: KEY EXECUTIVES
TABLE 160. LIVANOVA PLC: COMPANY SNAPSHOT
TABLE 161. LIVANOVA PLC: PRODUCT SEGMENTS
TABLE 162. LIVANOVA PLC: PRODUCT PORTFOLIO
TABLE 163. LIVANOVA PLC: KEY STRATERGIES
TABLE 164. BERLIN HEART GMBH: KEY EXECUTIVES
TABLE 165. BERLIN HEART GMBH: COMPANY SNAPSHOT
TABLE 166. BERLIN HEART GMBH: PRODUCT SEGMENTS
TABLE 167. BERLIN HEART GMBH: PRODUCT PORTFOLIO
TABLE 168. BERLIN HEART GMBH: KEY STRATERGIES
TABLE 169. JARVIK HEART, INC.: KEY EXECUTIVES
TABLE 170. JARVIK HEART, INC.: COMPANY SNAPSHOT
TABLE 171. JARVIK HEART, INC.: PRODUCT SEGMENTS
TABLE 172. JARVIK HEART, INC.: PRODUCT PORTFOLIO
TABLE 173. ABBOTT LABORATORIES: KEY EXECUTIVES
TABLE 174. ABBOTT LABORATORIES: COMPANY SNAPSHOT
TABLE 175. ABBOTT LABORATORIES: PRODUCT SEGMENTS
TABLE 176. ABBOTT LABORATORIES: PRODUCT PORTFOLIO
TABLE 177. ABBOTT LABORATORIES: KEY STRATERGIES
TABLE 178. SYNCARDIA SYSTEMS, LLC: KEY EXECUTIVES
TABLE 179. SYNCARDIA SYSTEMS, LLC: COMPANY SNAPSHOT
TABLE 180. SYNCARDIA SYSTEMS, LLC: PRODUCT SEGMENTS
TABLE 181. SYNCARDIA SYSTEMS, LLC: PRODUCT PORTFOLIO
TABLE 182. SYNCARDIA SYSTEMS, LLC: KEY STRATERGIES
TABLE 183. CH BIOMEDICAL, INC.: KEY EXECUTIVES
TABLE 184. CH BIOMEDICAL, INC.: COMPANY SNAPSHOT
TABLE 185. CH BIOMEDICAL, INC.: PRODUCT SEGMENTS
TABLE 186. CH BIOMEDICAL, INC.: PRODUCT PORTFOLIO
TABLE 187. CH BIOMEDICAL, INC.: KEY STRATERGIES
LIST OF FIGURES
FIGURE 01. VENTRICULAR ASSIST DEVICES MARKET, 2021-2031
FIGURE 02. SEGMENTATION OF VENTRICULAR ASSIST DEVICES MARKET, 2021-2031
FIGURE 03. TOP INVESTMENT POCKETS IN VENTRICULAR ASSIST DEVICES MARKET (2022-2031)
FIGURE 04. LOW BARGAINING POWER OF SUPPLIERS
FIGURE 05. LOW BARGAINING POWER OF BUYERS
FIGURE 06. LOW THREAT OF SUBSTITUTES
FIGURE 07. LOW THREAT OF NEW ENTRANTS
FIGURE 08. LOW INTENSITY OF RIVALRY
FIGURE 09. DRIVERS, RESTRAINTS AND OPPORTUNITIES: GLOBALVENTRICULAR ASSIST DEVICES MARKET
FIGURE 10. VENTRICULAR ASSIST DEVICES MARKET, BY PRODUCT, 2021(%)
FIGURE 11. COMPARATIVE SHARE ANALYSIS OF VENTRICULAR ASSIST DEVICES MARKET FOR LEFT VENTRICULAR ASSIST DEVICES (LVADS), BY COUNTRY 2021-2031(%)
FIGURE 12. COMPARATIVE SHARE ANALYSIS OF VENTRICULAR ASSIST DEVICES MARKET FOR RIGHT VENTRICULAR ASSIST DEVICES (RVADS), BY COUNTRY 2021-2031(%)
FIGURE 13. COMPARATIVE SHARE ANALYSIS OF VENTRICULAR ASSIST DEVICES MARKET FOR BIVENTRICULAR ASSIST DEVICES (BIVADS), BY COUNTRY 2021-2031(%)
FIGURE 14. VENTRICULAR ASSIST DEVICES MARKET, BY APPLICATION, 2021(%)
FIGURE 15. COMPARATIVE SHARE ANALYSIS OF VENTRICULAR ASSIST DEVICES MARKET FOR BRIDGE-TO-TRANSPLANT (BTT), BY COUNTRY 2021-2031(%)
FIGURE 16. COMPARATIVE SHARE ANALYSIS OF VENTRICULAR ASSIST DEVICES MARKET FOR DESTINATION THERAPY, BY COUNTRY 2021-2031(%)
FIGURE 17. COMPARATIVE SHARE ANALYSIS OF VENTRICULAR ASSIST DEVICES MARKET FOR BRIDGE-TO-RECOVERY (BTR), BY COUNTRY 2021-2031(%)
FIGURE 18. COMPARATIVE SHARE ANALYSIS OF VENTRICULAR ASSIST DEVICES MARKET FOR BRIDGE TO CANDIDACY THERAPY, BY COUNTRY 2021-2031(%)
FIGURE 19. VENTRICULAR ASSIST DEVICES MARKET, BY DESIGN, 2021(%)
FIGURE 20. COMPARATIVE SHARE ANALYSIS OF VENTRICULAR ASSIST DEVICES MARKET FOR TRANSCUTANEOUS VENTRICULAR ASSIST DEVICES, BY COUNTRY 2021-2031(%)
FIGURE 21. COMPARATIVE SHARE ANALYSIS OF VENTRICULAR ASSIST DEVICES MARKET FOR IMPLANTABLE VENTRICULAR ASSIST DEVICES, BY COUNTRY 2021-2031(%)
FIGURE 22. VENTRICULAR ASSIST DEVICES MARKET, BY AGE, 2021(%)
FIGURE 23. COMPARATIVE SHARE ANALYSIS OF VENTRICULAR ASSIST DEVICES MARKET FOR ADULTS, BY COUNTRY 2021-2031(%)
FIGURE 24. COMPARATIVE SHARE ANALYSIS OF VENTRICULAR ASSIST DEVICES MARKET FOR PEDIATRICS, BY COUNTRY 2021-2031(%)
FIGURE 25. VENTRICULAR ASSIST DEVICES MARKET BY REGION, 2021
FIGURE 26. U.S. VENTRICULAR ASSIST DEVICES MARKET, 2021-2031 ($MILLION)
FIGURE 27. CANADA VENTRICULAR ASSIST DEVICES MARKET, 2021-2031 ($MILLION)
FIGURE 28. MEXICO VENTRICULAR ASSIST DEVICES MARKET, 2021-2031 ($MILLION)
FIGURE 29. GERMANY VENTRICULAR ASSIST DEVICES MARKET, 2021-2031 ($MILLION)
FIGURE 30. FRANCE VENTRICULAR ASSIST DEVICES MARKET, 2021-2031 ($MILLION)
FIGURE 31. UK VENTRICULAR ASSIST DEVICES MARKET, 2021-2031 ($MILLION)
FIGURE 32. ITALY VENTRICULAR ASSIST DEVICES MARKET, 2021-2031 ($MILLION)
FIGURE 33. SPAIN VENTRICULAR ASSIST DEVICES MARKET, 2021-2031 ($MILLION)
FIGURE 34. REST OF EUROPE VENTRICULAR ASSIST DEVICES MARKET, 2021-2031 ($MILLION)
FIGURE 35. JAPAN VENTRICULAR ASSIST DEVICES MARKET, 2021-2031 ($MILLION)
FIGURE 36. CHINA VENTRICULAR ASSIST DEVICES MARKET, 2021-2031 ($MILLION)
FIGURE 37. AUSTRALIA VENTRICULAR ASSIST DEVICES MARKET, 2021-2031 ($MILLION)
FIGURE 38. INDIA VENTRICULAR ASSIST DEVICES MARKET, 2021-2031 ($MILLION)
FIGURE 39. SOUTH KOREA VENTRICULAR ASSIST DEVICES MARKET, 2021-2031 ($MILLION)
FIGURE 40. REST OF ASIA-PACIFIC VENTRICULAR ASSIST DEVICES MARKET, 2021-2031 ($MILLION)
FIGURE 41. BRAZIL VENTRICULAR ASSIST DEVICES MARKET, 2021-2031 ($MILLION)
FIGURE 42. SAUDI ARABIA VENTRICULAR ASSIST DEVICES MARKET, 2021-2031 ($MILLION)
FIGURE 43. SOUTH AFRICA VENTRICULAR ASSIST DEVICES MARKET, 2021-2031 ($MILLION)
FIGURE 44. REST OF LAMEA VENTRICULAR ASSIST DEVICES MARKET, 2021-2031 ($MILLION)
FIGURE 45. TOP WINNING STRATEGIES, BY YEAR
FIGURE 46. TOP WINNING STRATEGIES, BY DEVELOPMENT
FIGURE 47. TOP WINNING STRATEGIES, BY COMPANY
FIGURE 48. PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 49. COMPETITIVE DASHBOARD
FIGURE 50. COMPETITIVE HEATMAP: VENTRICULAR ASSIST DEVICES MARKET
FIGURE 51. TOP PLAYER POSITIONING, 2021
FIGURE 52. ABIOMED, INC.: NET REVENUE, 2019-2021 ($MILLION)
FIGURE 53. ABIOMED, INC.: REVENUE SHARE BY REGION, 2021 (%)
FIGURE 54. LIVANOVA PLC: NET REVENUE, 2019-2021 ($MILLION)
FIGURE 55. LIVANOVA PLC: REVENUE SHARE BY SEGMENT, 2021 (%)
FIGURE 56. LIVANOVA PLC: REVENUE SHARE BY REGION, 2021 (%)
FIGURE 57. ABBOTT LABORATORIES: NET SALES, 2019-2021 ($MILLION)
FIGURE 58. ABBOTT LABORATORIES: REVENUE SHARE BY SEGMENT, 2021 (%)
FIGURE 59. ABBOTT LABORATORIES: REVENUE SHARE BY REGION, 2021 (%)
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security